Objective: We recently demonstrated in our swine model of coronary artery spasm that enhanced myosin light chain (MLC) phosphorylations (both MLC mono-and diphosphorylations) play a central role in the pathogenesis of the spasm. However, the molecular mechanism for and the phosphorylation sites for the enhanced MLC phosphorylations were unknown. In the present study, we addressed these points using hydroxyfasudil, a novel inhibitor of protein kinases, which we found preferentially inhibits Rho-kinase. Methods: The specificity of the inhibitory effects of hydroxyfasudil on Rho-kinase, MLCK, MRCKb and PKC were examined by kinase assay in vitro. The left porcine coronary artery was chronically treated with interleukin-1b (IL-1b, 2.5 mg). Two weeks after the operation, coronary artery vasomotion was examined both in vivo and in vitro. MLC phosphorylations were examined by Western blot analysis and the sites for the phosphorylations by anti-phosphorylated MLC antibodies that identified the monophosphorylation site as Ser19 and diphophorylation sites as Ser19 / Thr18 of MLC. Results: Inhibitory effects of hydroxyfasudil was at least 100 times more potent for Rho-kinase as compared with other protein kinases tested. Intracoronary serotonin (10 mg / kg) caused coronary hyperconstriction at the IL-1b-treated site in vivo, which was dose-dependently inhibited by hydroxyfasudil ( p,0.01). The coronary segment taken from the spastic site also showed hypercontractions to serotonin in vitro, which were again dose-dependently inhibited by hydroxyfasudil ( p,0.01). Western blot analysis showed that MLC monophosphorylation was significantly greater in the spastic segment than in the control segment, while MLC diphosphorylation was noted only at the spastic segment ( p,0.01). The sites for the mono-and diphosphorylated MLC were identified as the monophosphorylated site Ser19 and diphosphorylated sites Ser19 / Thr18 of MLC, respectively. Both types of MLC phosphorylations at the spastic segment were markedly inhibited by hydroxyfasudil ( p,0.01). Conclusion: These results indicate that hydroxyfasudilsensitive Rho-kinase-mediated pathway appears to mediate the enhanced MLC phosphorylations (on Ser19 and Ser19 / Thr18 residues) and plays a central role in the pathogenesis of coronary artery spasm.
Introduction the mechanism(s) for coronary spasm, we have developed swine models of the spasm, in which we demonstrated the Coronary artery spasm plays an important role in a wide pathogenetic importance of coronary atherosclerosis in variety of ischemic heart diseases [1] . In order to elucidate general [2] and of inflammatory changes of the coronary artery in particular [3, 4] . The spasm induced in our swine models has many similarities to that observed in humans, indicating that our models are useful in elucidating the 2.1. Kinase assay pathogenesis of the spasm in humans [2] [3] [4] .
We have recently demonstrated in our swine models that The inhibitory effects of hydroxyfasudil on kinase a protein kinase C (PKC)-mediated pathway is substantialactivities were examined by kinase assay. The kinase ly involved [5, 6] while enhanced myosin light chain reaction for GST (glutathione S-transferase)-Rho-kinase-(MLC) phosphorylations (both mono-and diphosphoryla-CAT (catalytic domain) or GST-MRCKb (myotonic tions) play a central role in the pathogenesis of the spasm dystrophy kinase-related Cdc42-binding kinase beta)-CAT [7] . We also showed that fasudil, an inhibitor of both MLC was carried out in 50 ml of kinase buffer (50 mM Tris / kinase (MLCK) and PKC [8, 9] , inhibited the coronary HCl at pH 7.5, 2 mM EGTA, 1 mM EDTA, 5 mM MgCl , 2 32 spasm and the enhanced MLC phosphorylations in our 3 mM KCl) containing 100 mM [g-P]ATP (1-20 GBq / swine model [7] . However, the detailed intracellular mmol), recombinant kinase, and 2 mM MLC. The kinase mechanism for and the phosphorylation sites for the reaction for MLCK was carried out in 50 ml of kinase enhanced MLC phosphorylations remained to be elucibuffer (30 mM Tris / HCl at pH 7.5, 0.1 mM CaCl , 1 mM 2 dated. MgCl , 30 mM KCl, 5 mg / ml calmodulin) containing 100 2 32 Studies in vitro demonstrated that a GTP-binding protein mM [g-P]ATP (1-20 GBq / mmol), MLCK, and 2 mM regulates the receptor-mediated sensitization of the MLC MLC. After incubation for 10 min at 308C, the reaction phosphorylation [10] and that small GTPase Rho is mixtures were boiled in SDS sample buffer and subjected 21 involved in the GTP-enhanced Ca sensitivity of the to SDS-PAGE. The radiolabelled bands were visualized smooth muscle contraction [11] [12] [13] . Recent studies further by an image analyzer (Fuji). demonstrated that Rho regulates MLC phosphorylation
The kinase reaction for GST-Rho-kinase-CAT or GSTthrough its targets, Rho-kinase and the myosin binding MRCKb-CAT was carried out in 50 ml of kinase buffer subunit (MBS) of myosin phosphatase [14, 15] . Activated (50 mM Tris / HCl at pH 7.5, 2 mM EGTA, 1 mM EDTA, 32 Rho interacts with Rho-kinase and MBS of myosin 5 mM MgCl ) containing 100 mM [g-P]ATP (1-20   2 phosphatase, to activate Rho-kinase and translocate MBS. GBq / mmol), GST-Rho-kinase-CAT, and 40 mM rsk kiThe activated Rho-kinase subsequently phosphorylates nase S6 substrate. The kinase reaction for PKC (a and b) MBS, thereby inactivating myosin phosphatase [14] . Rhowas carried out in 50 ml of kinase buffer (20 mM Tris / kinase itself may phosphorylate MLC at the same site that HCl at pH 7.5, 0.5 mM CaCl , 5 mM MgCl , 20 mg / ml 2 2 is phosphorylated by MLC kinase, and activate myosin phosphatidyl serine, 100 nM 12-O-tetradecanoylphorbol 32 ATPase [15] . Activated form of Rho-kinase enhances b-acetate) containing 100 mM [g-P]ATP (1-20 GBq / MLC phosphorylation [16] and induces smooth muscle mmol), PKC, and 40 mM PKC pseudo-substrate peptide. contraction [17] , stress fiber formation and neurite retracAfter incubation for 10 min at 308C, the reaction mixtures tion [18] . Both pathways, inhibition of myosin phosphatase were spotted onto a Whatman p81 paper and washed with 32 and direct phosphorylation of MLC, may be involved in 75 mM phosphoric acid three times. Incorporation of P the increase in the MLC phosphorylation [17] .
into the substrates was assessed by scintillation counting. As we discuss later, we recently found that hydroxyThe inhibitory effect of hydroxyfasudil was expressed as fasudil, an active metabolite of fasudil [19] , preferentially IC50 values and inhibition constant (K ) values, as reported i inhibits Rho-kinase. Thus, the present study was designed previously [8, 9] . to further elucidate the intracellular mechanism for coronary spasm using hydroxyfasudil and to identify the 2.2. Animal preparation phosphorylation sites for the enhanced MLC phosphorylations in our swine model. Our findings clearly indicated Male Yorkshire pigs weighing 25 to 30 kg were sedated that hydroxyfasudil-sensitive Rho-kinase-mediated pathwith ketamine hydrochloride (12.5 mg / kg IM) and anesway appears to mediate the enhanced MLC phosphorylathetized with sodium pentobarbital (25 mg / kg IV). The tions (on Ser19 and Ser19 / Thr18) and plays a central role animals were then intubated and ventilated with room air; in the pathogenesis of coronary artery spasm.
oxygen was supplemented via a positive-pressure respirator (Shinano artery [3, 4, 6 ].
Preparation of IL-1b beads
as at the untreated segments of a comparable diameter [3] [4] [5] [6] . IL-1b beads were prepared as follows [3, 4] . One gram of sepharose microbeads (45 to 165 mm in diameter) was 2.5. In vitro experiment added to 50 ml of 1 mmol / l HCl solution and resuspended in 20 ml NaHCO / NaCl solution with 1 mg IL-1b. The 3 Three to four days after the in vivo experiments, when beads were allowed to bind with IL-1b at room temperathe effects of hydroxyfasudil had totally disappeared, the ture for 1 h and then at 48C overnight. After centrifugation animals were sedated with ketamine hydrochloride (12.5 at 1200 rpm for 5 min, the supernatant was separated, and mg / kg IM) and sacrificed with a lethal dose of sodium the concentration of the remaining IL-1b in the supernatant pentobarbital, exsanguinated, and then the heart was was measured by an ELISA [3, 4] . The IL-1b-bound beads excised. The coronary arteries at the IL-1b-treated and in the pellet were resuspended in 20 ml NaHCO / NaCl 3 control sites were carefully dissected and cleaned of any solution and centrifuged four times at 1200 rpm for 5 min.
perivascular tissue and cut into rings measuring |4 mm in Then the IL-1b-bound beads were resuspended with Trislength. The strips were fixed vertically between hooks in HCl buffer solution for 1 h and finally washed and an organ bath of 20 ml capacity containing Krebs-Henresuspended so that the concentration of IL-1b was 50 seleit solution, which was maintained at 378C and aerated mg / ml. All preparations were performed under sterile with a mixture of 95% O 25% CO [7] . The hook 2 2 conditions [3, 4, 6] . anchoring the upper end of the strip was connected to the Since in our bead preparation most of the IL-1b lever of a force transducer (Nihon-Kohden Kogyo, Tokyo, molecules are bound inside the beads by a covalent bond at Japan). The resting tension was adjusted to 5 g. KCl the amino residues of the proteins, 1.2% or less of the solution (62 mM) was applied every 15-20 min until the IL-1b molecules are actually bound to the surface of the amplitude of the contraction reached a constant value. The beads and biologically active. Thus, when 2.5 mg of IL-1b tension was represented as a percentage of the tension bound to the beads is applied to the coronary artery, , 30 attained in the last precontraction with 62 mM KCl. The ng of IL-1b is biologically active [3] .
contractions to serotonin were examined in the absence 26 and presence of different doses of hydroxyfasudil (10 25 and 10 mol / l), which was added 10 min before addition 2.4. In vivo experiment of serotonin.
Two weeks after the operation, we performed a coronary arteriographic study in which the coronary artery vasomo-2.6. Measurements of MLC phosphorylations tion was examined in vivo.
The animals were again anesthetized and ventilated as The extent of MLC phosphorylation in the strips was described above, and selective coronary arteriography was measured by separation of non-, mono-, and diphosperformed. A preshaped Judkins catheter was inserted into phorylated forms by glycerol-polyacrylamide gel electrothe right or left femoral artery, and then coronary arteriogphoresis (PAGE) followed by electrophoretic transfer of raphy in a left anterior oblique view was performed under the proteins to a nitrocellulose membrane. The relative control conditions and after intracoronary nitroglycerin 10 amounts of each form were quantified by immunoblot mg / kg. ECGs (leads I, II, III, V1, and V6), along with the procedures, as described previously [7] . mean arterial pressure and heart rate, were recorded Rings mounted for isometric studies were frozen by continuously during the experiments. Coronary arterioimmersion in acetone containing 10% trichloroacetic acid graphy was repeated 2 min after the intracoronary adminis-(TCA) and 10 mM dithiothreitol (DTT) cooled with dry tration of serotonin (10 mg / kg). Then, intracoronary ice. Frozen tissues were washed twice with acetone administration of hydroxyfasudil at three different doses containing 10 mM DTT to remove the TCA and then (10, 30, and 100 mg / kg) was performed, and the coronary dried. The dried ring was cut into small pieces, exposed to vasomotion to serotonin was again evaluated at each dose 80 ml of glycerol-PAGE sample buffer for purposes of of hydroxyfasudil.
extraction, and then passed through a 0.45-mm membrane The cineangiograms were projected on a screen using a filter. The urea-solubilized samples (5 ml) were subjected cineprojector (ELX-35CB; Nishimoto Sangyo, Osaka, to glycerol-PAGE / immunoblot analysis, using the specific Japan), and an end-diastolic frame was selected and printed MLC antibody [18] . The region containing MLC was [3] [4] [5] [6] . The coronary luminal diameters were measured by visualized using an ECL Western blotting system (Amercomputer-assisted quantitative coronary angiogram system sham). The extent of MLC phosphorylation is expressed as (Sony, Tokyo, Japan). The degree of constrictive response the percent MLC in the mono-and diphosphorylated was expressed as the percent decrease in the luminal forms, respectively. The validity of the MLC phosphoryladiameter from the control level. The coronary diameter tion assay system was demonstrated by using MLC was measured at the segments treated with IL-1b as well specific phosphatase purified from chicken gizzard [20] .
Measurement of phosphorylation on Ser19 and
MRCKb-CAT (1-550 amino acids) were produced in Sf9 Ser19 /Thr18 of MLC cells with a baculovirus system [23] and purified on a glutathione-sepharose column [24] . rsk kinase S6 subRelative amounts of phosphorylated Ser19 residue or strate (RRRLSSLRA) and PKC pseudo-substrate Ser19 / Thr18 residues in the MLC molecule in arteries (RFARKGSLRQKNVHEVK) were synthesized. [g- 32 were determined using SDS PAGE followed by immuno-P]ATP was purchased from Amersham. Serotonin (5-blot method using specific antibodies which specifically hydroxytryptamine) was purchased from Sigma Chemical, recognize monophosphorylated MLC at Ser19 (anti-MLCand hydroxyfasudil [19] was provided from Asahi Chemi-P antibody) [21] or diphosphorylated MLC at Ser19 and cal. Dilution was done with a physiological salt solution. Thr18 (anti-MLC-P2 antibody) [22] . SDS sample buffer (15 ml) containing 12.5% SDS, 25% 2-mercaptoethanol, 2.9. Statistical analysis 50 mM tris(hydroxymethyl) aminomethane, 50% sucrose and 0.1% bromophenol blue was added to the above The results were expressed as mean6SEM. Throughout mentioned urea-solubilized samples (60 ml), which were the text, n represents the number of animals tested. A then boiled for 5 min. The samples (20 ml each) were repeated-measures ANOVA was performed to evaluate applied to three sets of 15% polyacrylamide SDS gels global statistical significance, and if a significant F value (BioRad, Richmond, CA) and subjected to electrophoresis was found, Scheffe's test was performed to identify the at 20 mA for 3 h. Electophoretic transfer of proteins from difference among the groups. A value of p,0.05 was SDS-PAGE gels onto nitrocellulose membranes were considered to be statistically significant. carried out in buffer containing 20 mM tris (hydroxymethyl) aminomethane, 20% methanol, with application of 6 V/ cm for 1 h. Three sets of nitrocellulose membranes were incubated with anti-MLC antibody, anti-MLC-P 3. Results antibody or anti-MLC-P2 antibody, respectively. For detection of immunoreacted bands, we used an ECL Western 3.1. Specific inhibitory effects of hydroxyfasudil on Rhoblotting system (Amersham). The ratio of staining density kinase of Ser19 or Ser19 / Thr18 to that of total MLC in preparations before stimulation with serotonin was expressed as When examined using MLC as a substrate, hydroxy-1.0.
fasudil potently inhibited the activity of recombinant Rhokinase in a dose-dependent manner (IC50 1.8 mM), while 2.8. Materials and chemicals its inhibitory effect was markedly (at least 100 times) less for MRCKb or MLCK (Fig. 1A) . When examined using GST-Rho-kinase-CAT (6-553 amino acids) and GSTpeptide as a substrate, hydroxyfasudil again potently inhibited Rho-kinase (IC50 0.9 mM), while its inhibitory effect was markedly less for PKC (IC50 100 mM) (Fig.  1B) . These results indicate that hydroxyfasudil preferentially inhibits the Rho-kinase activity in vitro.
In vivo study
Two weeks after the operation, serotonin (10 mg/kg IC) repeatedly caused hyperconstriction at the IL-1b-treated site in vivo (Fig. 2) . The pretreatment with hydroxyfasudil did not significantly change heart rate or blood pressure (data not shown). This pretreatment with hydroxyfasudil dose-dependently inhibited the serotonin-induced coronary spasm at the IL-1b-treated site in vivo, while at the control site its inhibitory effect on the serotonin-induced contraction was not evident (Figs. 2 and 3 ). induced a contraction of the IL-1b-treated and control coronary segments with endothelium, which rapidly developed and reached a maximum after the first 5-8 min, treated coronary segments compared to the control segfollowed by a slight decrease and then by a sustained ments in vitro (Fig. 4) . The pretreatment with hydroxyresponse. Serotonin caused hypercontractions in the IL-1b-fasudil dose-dependently inhibited the serotonin-induced levels under control conditions, while the MLC diphosphorylations were abolished by hydroxyfasudil (Fig. 6 ). In contrast, in the control coronary segments hydroxyfasudil inhibited the increased MLC monophosphorylations to the levels under control conditions (Fig. 6) . The increase in MLC monophosphorylations tended to be correlated with and that in MLC diphosphorylations significantly correlated with the extent of the serotonininduced contractions (Fig. 7) . When the increases in MLC mono-and diphosphorylations were combined, the summed increase in MLC phosphorylations significantly correlated with the extent of serotonin-induced contractions (Fig. 7) . 
In vitro study

Measurement of phosphorylation on Ser19 and
The extent of contraction is expressed as percentage of the contraction to Ser19 /Thr18 of MLC 62 mmol / l KCl. Data are presented as mean6SEM.
hypercontractions of the spastic coronary segments, while
Relative amount of phosphorylated Ser19 residue of the higher concentrations of hydroxyfasudil also inhibited the MLC molecule in the IL-1b-treated and control arteries serotonin-induced contractions of the normal coronary were compared with that of total monophosphorylated segments (Fig. 4) .
MLC determined using glycerol-PAGE followed by the immunoblot method (Fig. 8A ). There was a close analogy 3.4. MLC phosphorylations between the relative amount of phosphorylated Ser19 in MLC and total monophosphorylated MLC. These results The extent of MLC mono-and diphosphorylation was suggest that the phosphorylation site of monophosmeasured when the serotonin-induced contraction of each phorylated form of MLC induced by serotonin is mainly ring reached a maximum. Glycerol-PAGE followed by Ser 19 residue of MLC in both the spastic and control Western blot analysis showed that MLC monophosphorylaarteries. tion was significantly increased both in the IL-1b-treated Relative amount of phosphorylated Ser19 / Thr18 resand the control segments (Figs. 5 and 6 ), while MLC idues on the MLC molecule increased in IL-1b-treated diphosphorylation was noted only at the IL-1b-treated arteries (Fig. 8B) . However, we were unable to compare segment (Figs. 5 and 6 ). In the spastic coronary segments, the relative amount of phosphorylated Ser19 / Thr18 with the enhanced MLC monophosphorylations were markedly total diphosphorylated MLC determined using glyceroland dose-dependently inhibited by hydroxyfasudil to the PAGE followed by immunoblot method, because the diphosphorylated MLC in non-stimulated arteries could not 4. Discussion be detected by glycerol-PAGE method. The anti-MLC-P2 antibody may be much more sensitive in recognizing the The novel findings of the present study were that (a) phosphorylated Ser19 / Thr18 residues on the MLC as hydroxyfasudil is a specific inhibitor of Rho-kinase, (b) the compared with anti-MLC antibody.
mono-and diphosphorylation sites of MLC in the spastic artery were Ser19 and Ser19 / Thr18, respectively and (c) Recently Rho-kinase has also been reported to phosphorhydroxyfasudil significantly inhibited the enhanced MLC ylate MLC in vitro [15] . MLCK and Rho-kinase prefphosphorylations as well as the spasm both in vivo and in erentially phosphorylates Ser19 residues on MLC and vitro. Thus, the present study clearly demonstrates that the activates myosin ATPase [25, 27, 28] . Phosphorylation of enhanced MLC phosphorylations in the vascular smooth the second site (Thr18) of MLC by MLCK further muscle play a central role in the pathogenesis of coronary increased myosin ATPase activity [29] . PKC also phosspasm and that hydroxyfasudil-sensitive Rho-kinase-mephorylates MLC at multiple sites (Ser1, Ser2 and Thr9), diated pathway appears to be involved in those enhanced however, PKC can not activate myosin ATPase [26] . Thus, MLC phosphorylations. To the best of our knowledge, this it is important to determine the phosphorylated sites of is the first report that elucidated the important role of MLC in the spastic artery. Glycerol-PAGE followed by Rho-kinase-mediated pathway in the pathogenesis of corthe immunoblot method using anti-MLC antibody does not onary artery spasm and identified the MLC phosphorylaquantitatively separate the MLCK or Rho-kinase-depention sites of the spastic coronary artery. dent phosphorylation of MLC from PKC-dependent one. We raised a monoclonal antibody against a Ser19 site 4.1. Phosphorylation sites of MLC in the spastic phosphorylated MLC [21] and a polyclonal antibody coronary artery against Ser19 / Thr18 sites phosphorylated MLC [22] . Using these antibodies, we were able to demonstrate that We have recently demonstrated that coronary spasm is phosphorylations of Ser19 site and Ser19 / Thr18 sites of associated with an enhanced and sustained MLC mono-MLC were enhanced in the spastic coronary arteries. We phosphorylation and an appearance of MLC diphosdid not examine the phosphorylations of Ser1, Ser2, or phorylation [7] (Fig. 9) . It has been reported that MLC is Thr9 residues, which are directly mediated by PKC [26] . phosphorylated by MLCK and PKC in vitro [25, 26] .
However, the contribution of these MLC phosphorylations to the occurrence of the spasm may be minimal partly for MLCK (36 mM). These results suggest that hydroxybecause the phosphorylations of Ser19 site and Ser19 / fasudil-sensitive Rho-kinase-mediated pathway plays an Thr18 sites of MLC are largely responsible for the spasm important role in the enhanced MLCK-dependent MLC (e.g. positive correlation between the phosphorylations and phosphorylations in the spastic coronary artery (Fig. 9) . the developed tensions) and partly because PKC does not
The level of MLC phosphorylation is determined by a activate myosin ATPase or does not lead force generation balance between MLC phosphorylation and dephosor contractions [24] .
phorylation [25, 27] (Fig. 9) . We recently suggested that the generation of diphosphorylated MLC may be caused in 4.2. Rho-kinase-mediated pathway and coronary spasm part by the inhibition of MLC phosphatase in smooth muscle cells [30] . We also showed that treatment with We found that hydroxyfasudil preferentially inhibits 10-100 nmol / l calyculin A, a protein phosphatase inhibRho-kinase compared to MLCK, MRCK b, or PKC (Fig. itor, potently induced MLC diphosphorylation in smooth 21 1). In the present study, hydroxyfasudil preferentially muscle cells without an increase in intracellular Ca inhibited the enhanced components of coronary artery levels [30] . Recently we found that the direct increase in 21 21 contractions and the MLC phosphorylations at the spastic intracellular Ca levels by the Ca ionophore did not site, while at the control site its inhibitory effects on the result in an increase in diphosphorylated MLC (unpubcontractions and MLC phosphorylations were less promilished data). Noda et al. [12] reported that in permeabilized nent. Hydroxyfasudil is quite different from fasudil as it porcine aortic smooth muscle cells the increase in intracel- 21 does not inhibit MLCK; calculated K value of hydroxylular Ca levels caused monophosphorylation of MLC i fasudil for MLCK is more than 300 mM (Fig. 1) , which is alone, while additional treatment with GTP-gS, which is in contrast to the previously reported K value of fasudil thought to inactivate MLC phosphatase, caused both mono-and diphosphorylation of MLC. These results
